Management of ocular allergy

dc.contributor.authorLeonardı, Andrea
dc.contributor.authorSilva, Diana
dc.contributor.authorPerez Formigo, Daniel
dc.contributor.authorBozkurt, Banu
dc.contributor.authorSharma, Vibha
dc.contributor.authorAllegri, Pia
dc.contributor.authorRondon, Carmen
dc.contributor.authorCalder, Virginia
dc.contributor.authorRyan, Dermot
dc.contributor.authorL. Kowalsk, Marek
dc.contributor.authorDelgado, Luis
dc.contributor.authorDoan, Serge
dc.contributor.authorL. Fauquert, Jean
dc.date.accessioned2020-03-26T20:19:57Z
dc.date.available2020-03-26T20:19:57Z
dc.date.issued2019
dc.departmentSelçuk Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractThe treatment and management of ocular allergy (OA) remain a major concern for different specialties, including allergists, ophthalmologists, primary care physicians, rhinologists, pediatricians, dermatologists, clinical immunologists, and pharmacists. We performed a systematic review of all relevant publications in MEDLINE, Scopus, and Web Science including systematic reviews and meta-analysis. Publications were considered relevant if they addressed treatments, or management strategies of OA. A further wider systematic literature search was performed if no evidence or good quality evidence was found. There are effective drugs for the treatment of OA; however, there is a lack an optimal treatment for the perennial and severe forms. Topical antihistamines, mast cell stabilizers, or double-action drugs are the first choice of treatment. All of them are effective in reducing signs and symptoms of OA. The safety and optimal dosing regimen of the most effective topical anti-inflammatory drugs, corticosteroids, are still a major concern. Topical calcineurin inhibitors may be used in steroid-dependent/resistant cases of severe allergic keratoconjunctivitis. Allergen-specific immunotherapy may be considered in cases of failure of first-line treatments or to modify the natural course of OA disease. Based on the current wealth of publications and on the collective experience, recommendations on management of OA have been proposed. © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.en_US
dc.description.sponsorshipFunding information This work was done under the approval of EAACI with a TF budget 2015-18.en_US
dc.identifier.citationLeonardı, A., Silva, D., Perez Formigo, D., Bozkurt, B., Sharma, V., Allegri, P., Rondon, C., Calder, V., Ryan, D., L. Kowalsk, M., Delgado, L., Doan, S., L. Fauquert, J. (2019). Management of Ocular Allergy. Allergy: European Journal of Allergy and Clinical Immunology, 74,(9), 1611-1630.
dc.identifier.doi10.1111/all.13786en_US
dc.identifier.endpage1630en_US
dc.identifier.issn0105-4538en_US
dc.identifier.issue9en_US
dc.identifier.pmid30887530en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1611en_US
dc.identifier.urihttps://dx.doi.org/10.1111/all.13786
dc.identifier.urihttps://hdl.handle.net/20.500.12395/38458
dc.identifier.volume74en_US
dc.identifier.wosWOS:000582627000001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorBozkurt, Banu
dc.language.isoenen_US
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofAllergy: European Journal of Allergy and Clinical Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectallergic conjunctivitisen_US
dc.subjectmanagementen_US
dc.subjectocular allergyen_US
dc.subjectsystematic reviewen_US
dc.subjecttreatmenten_US
dc.titleManagement of ocular allergyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
BANU BOZKURT.pdf
Boyut:
1.04 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text Access